- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cochlear implant for single-sided deafness improves tinnitus and vertigo
A new study by Morelli and peers found that after at least six months of follow-up, cochlear implant (CI) in patients with single-sided deafness (SSD) is a useful tool for an overall improvement in tinnitus and vertigo as well as quality of life. The findings of this study were published in European Archives of Oto-Rhino-Laryngology.
The main objective of this study was to analyze the results of patients who have single-sided deafness cochlear implants. The research group was composed of all SSD patients who received CI at Gruppo Otologico, Piacenza, between October 2012 and May 2022 with at least 6 months of follow-up. Pre-operatively and up to 24 months following surgery, subjective and objective measurements were included in the study. Pure tone audiometry and speech audiometry were used to evaluate the hearing threshold on both sides using a weighted four-frequency average (PTA [0.5 kHz + 1 kHz + 2 kHz + 4 kHz]/4) (Speech Discrimination Score, SDS). For subjective evaluation, the Tinnitus Handicap Inventory Questionnaire (THI), Dizziness Handicap Inventory Questionnaire (DHI), and Speech Spatial and Qualities of Hearing scale (SSQ Questionnaire) were utilized.
The key findings of this study were:
1. Data from 138 individuals who underwent CI for SSD were reviewed.
2. There were 69 men and 69 women (mean age, range, 17–77 years).
3. Prior to having CI surgery, single-sided hearing loss lasted an average of 2.5 years (between 3 months and 35 years).
4. The THI and DHI scores were significantly lower than pre-operative levels, and the SSQ questionnaire also indicated an improvement in social, physical, and emotional well-being.
In a single institution, this paper described the largest cohort of SSD patients who underwent CI. After at least six months of follow-up, the results show that CI in patients with SSD is a useful tool for a general improvement in tinnitus and vertigo as well as quality of life. It would be ideal to do further research to enhance rehabilitation programs and even establish new guidelines for treating this ailment.
Reference:
Morelli, L., Fancello, V., Gaino, F., Cagliero, G., Caruso, A., & Sanna, M. (2023). Cochlear implantation in single-sided deafness: a single-center experience of 138 cases. In European Archives of Oto-Rhino-Laryngology. Springer Science and Business Media LLC. https://doi.org/10.1007/s00405-023-07959-1
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751